Stephen Davis, CEO at ACADIA PHARMACEUTICALS INC (ACAD), sold 7,464 shares at $29.96 ($224K) on 2024-01-08, disclosed to the SEC on 2024-01-09.
Seasonal sale ($224k) by CEO — this insider has traded ACAD in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.96 | 3,732 | $112K | 50.0% |
| 2 | $29.96 | 3,732 | $112K | 50.0% |
| Total | $29.96 avg | 7,464 | $224K | 100% |
| Filing → |
| ACAD | SELL | 2024-04-09 | $950K | — | Filing → |
| ACAD | SELL | 2024-03-27 | $634K | — | Filing → |
| ACAD | SELL | 2024-02-27 | $275K | — | Filing → |